Healthcare provider profile · identity verified

Hilda Rivera-Rivera

Internal Medicine · SPRINGFIELD, MA · NPI 1225247521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	117
Lisinopril	Lisinopril	357	69
Trulicity	Dulaglutide	357	46
Gabapentin	Gabapentin	313	45
Omeprazole	Omeprazole	286	61
Metformin Hcl	Metformin Hcl	260	54
Metoprolol Succinate	Metoprolol Succinate	260	49
Levothyroxine Sodium	Levothyroxine Sodium	243	34
Amlodipine Besylate	Amlodipine Besylate	225	42
Fluticasone Propionate	Fluticasone Propionate	207	58
Losartan Potassium	Losartan Potassium	186	32
Jardiance	Empagliflozin	179	38
Ventolin Hfa	Albuterol Sulfate	165	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	157	26
Albuterol Sulfate Hfa	Albuterol Sulfate	146	33
Pantoprazole Sodium	Pantoprazole Sodium	137	25
Hydrochlorothiazide	Hydrochlorothiazide	135	27
Oxycodone Hcl	Oxycodone Hcl	123	28
Montelukast Sodium	Montelukast Sodium	121	17
Eliquis	Apixaban	116	20
Citalopram Hbr	Citalopram Hydrobromide	114	18
Carvedilol	Carvedilol	105	16
Novolog Flexpen	Insulin Aspart	101	19
Furosemide	Furosemide	100	22
Tamsulosin Hcl	Tamsulosin Hcl	99	14
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	97	97
Fluticasone Propionate Hfa	Fluticasone Propionate	76	15
Famotidine	Famotidine	72	19
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	72	15
Diclofenac Sodium	Diclofenac Sodium	66	31
Simvastatin	Simvastatin	64	13
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	63	17
Meloxicam	Meloxicam	60	21
Trazodone Hcl	Trazodone Hcl	56	18
Clopidogrel	Clopidogrel Bisulfate	54	11
Spironolactone	Spironolactone	54	suppressed
Chlorthalidone	Chlorthalidone	52	13
Lantus	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	51	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	44	15
Ezetimibe	Ezetimibe	41	suppressed
Metformin Hcl Er	Metformin Hcl	41	suppressed
Farxiga	Dapagliflozin Propanediol	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Allopurinol	Allopurinol	36	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Clotrimazole	Clotrimazole	31	20
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Dulera	Mometasone/Formoterol	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Naproxen	Naproxen	21	suppressed
Ozempic	Semaglutide	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	17
Terazosin Hcl	Terazosin Hcl	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Topiramate	Topiramate	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Nystatin	Nystatin	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Pulmicort Flexhaler	Budesonide	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Finasteride	Finasteride	15	suppressed
Single Use Swab	Alcohol Antiseptic Pads	15	suppressed
Sure Comfort	Pen Needle, Diabetic	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Levemir	Insulin Detemir	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Zafirlukast	Zafirlukast	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Atenolol	Atenolol	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Easy-Touch Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Niacin Er	Niacin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error